Mydecine Reports Delay and Progress Amid MCTO

Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update.

Mydecine Innovations Group Inc. has announced a delay in its fiscal year-end financial reporting and is under a management cease trade order (MCTO), but assures investors that the auditing process is advancing. The company’s top executives are restricted from trading its shares, though trading remains open to the public. Bi-weekly status updates will continue as the company works to resolve the filing delay.

For further insights into TSE:MYCO stock, check out TipRanks’ Stock Analysis page.